UNSPSC 51285505: Oxibetaine

This classification denotes an anti-lipidemic agent with the molecular formula C6H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y0WVV18VUI, chemically known as n-(2-hydroxyethyl) n,n-dimethylammonioacetat but generally known as oxibetaine, which bears US NIH Compound Identifier 168886. European Medicines Agency schedules Oxibetaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09522MIG. The term OXIBETAINE is an International Non-Proprietary Name.

UNSPSC 51285505 Oxibetaine, a Commodity code, does not map to active state and local procurement activity in the recent opportunities block. The two records present—an Illinois Department of Public Health piggyback pharmaceutical contract for antibiotics (Doxycycline and Ciprofloxacin) awarded to Chartwell Rx LLC, and a Seminole County, Florida IFB for Naloxone and drug deactivation systems—fall outside the scope of oxibetaine procurement and represent either awarded contracts or misclassified solicitations rather than open opportunities soliciting this specific pharmaceutical ingredient.

No open solicitations for oxibetaine or state and local procurement activity under this code are evident in the source material. Business development professionals should verify whether state and local purchasing offices are using this code for active procurement before allocating resources to pursue opportunities under it.